Cargando…
Anabolic treatments for osteoporosis in postmenopausal women
Antiresorptive agents are generally recommended as first-line treatment for osteoporosis in postmenopausal women. These drugs suppress bone resorption but do not rebuild bone, limiting their efficacy. Antiresorptive use is further hampered by concerns over rare side effects, including atypical femor...
Autores principales: | Hassan, Neelam, Gregson, Celia L, Tobias, Jon H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170684/ https://www.ncbi.nlm.nih.gov/pubmed/34131654 http://dx.doi.org/10.12703/r/10-44 |
Ejemplares similares
-
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
por: Min, Yong-Ki
Publicado: (2015) -
A review of anabolic therapies for osteoporosis
por: Lane, Nancy E, et al.
Publicado: (2003) -
Anabolic Therapies in Osteoporosis and Bone Regeneration
por: Russow, Gabriele, et al.
Publicado: (2018) -
Anabolic therapy for osteoporosis: update on efficacy and safety
por: Bandeira, Leonardo, et al.
Publicado: (2022) -
Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)